Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
10:03am, Wednesday, 05'th Mar 2025
A German court in Duesseldorf on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna.
Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80%
04:10am, Tuesday, 04'th Mar 2025
The S&P 500 has soared in recent times, delivering two consecutive years of double-digit gains, and investors -- from billionaires to small retail investors -- have piled into some of the biggest winn
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
09:15am, Monday, 03'rd Mar 2025
BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
10:30am, Friday, 28'th Feb 2025
mRESVIA ® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products R
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
03:15am, Friday, 28'th Feb 2025
Investors looking for growth in recent times have piled into stocks in artificial intelligence and quantum computing. But these aren't the only areas that offer the potential for explosive revenue gro
Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs
01:20am, Friday, 28'th Feb 2025
SHANGHAI , Feb. 28, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializi
Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds
02:30pm, Thursday, 27'th Feb 2025
Moderna stock toppled Thursday on reports the Trump administration is considering pulling bird flu vaccine funding. The post Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Fl
Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award
11:08am, Thursday, 27'th Feb 2025
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
10:05am, Thursday, 27'th Feb 2025
Moderna (MRNA -6.67%) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. But you may be surprised to learn that now you can buy the stock around the
FDA Vaccine Panel Meeting To Discuss Flu Shots Reportedly Canceled
02:53am, Thursday, 27'th Feb 2025
A meeting of the Food and Drug Administration's vaccine advisory committee to discuss the next season's flu vaccine has reportedly been canceled, the second such disruption of a meeting involving vacc
Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports
07:38pm, Wednesday, 26'th Feb 2025
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
08:00am, Tuesday, 25'th Feb 2025
SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026 Joint R&D project between SK and CEPI includes up to
Moderna to Present at Upcoming Conferences in March 2025
07:00am, Tuesday, 25'th Feb 2025
CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 45th Annual Health Care C
CancerVax Announces Successful Tests of its Smart mRNA Technology
03:01am, Tuesday, 25'th Feb 2025
Recent in-vitro lab results confirm that the Company's proprietary Smart mRNA can be used as a potential on/off switch for selectively detecting cancer cells Recent in-vitro lab results confirm that t
Moderna (MRNA) International Revenue Performance Explored
10:15am, Monday, 24'th Feb 2025
Explore how Moderna's (MRNA) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
